- Home
- NVCR vs STAA Comparison
NVCR vs STAA Comparison
Compare NVCR & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- STAA
- Stock Information
- Founded
- NVCR 2000
- STAA 1982
- Country
- NVCR Jersey
- STAA United States
- Employees
- NVCR N/A
- STAA N/A
- Industry
- NVCR Medical/Dental Instruments
- STAA Ophthalmic Goods
- Sector
- NVCR Health Care
- STAA Health Care
- Exchange
- NVCR Nasdaq
- STAA Nasdaq
- Market Cap
- NVCR 1.8B
- STAA 2.0B
- IPO Year
- NVCR 2015
- STAA N/A
- Fundamental
- Price
- NVCR $17.49
- STAA $30.20
- Analyst Decision
- NVCR Buy
- STAA Buy
- Analyst Count
- NVCR 5
- STAA 7
- Target Price
- NVCR $26.60
- STAA $45.00
- AVG Volume (30 Days)
- NVCR 1.3M
- STAA 605.4K
- Earning Date
- NVCR 10-30-2024
- STAA 10-30-2024
- Dividend Yield
- NVCR N/A
- STAA N/A
- EPS Growth
- NVCR N/A
- STAA N/A
- EPS
- NVCR N/A
- STAA 0.33
- Revenue
- NVCR $549,964,000.00
- STAA $332,942,000.00
- Revenue This Year
- NVCR $16.23
- STAA $8.76
- Revenue Next Year
- NVCR $6.09
- STAA $14.28
- P/E Ratio
- NVCR N/A
- STAA $91.84
- Revenue Growth
- NVCR 8.33
- STAA 8.83
- 52 Week Low
- NVCR $10.87
- STAA $26.66
- 52 Week High
- NVCR $24.74
- STAA $52.68
- Technical
- Relative Strength Index (RSI)
- NVCR 43.24
- STAA 41.25
- Support Level
- NVCR $15.61
- STAA $29.91
- Resistance Level
- NVCR $17.31
- STAA $31.41
- Average True Range (ATR)
- NVCR 1.29
- STAA 1.07
- MACD
- NVCR 0.05
- STAA -0.08
- Stochastic Oscillator
- NVCR 11.59
- STAA 15.56
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About STAA STAAR Surgical Company
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company also makes lenses that are used in surgery to treat cataracts. The company offers two types of products: Implantable Collamer lenses (ICL) and intraocular lens (IOL). The ICLs are used in refractive surgery and IOLs are used in cataract surgery. The majority of sales are generated from the ophthalmic surgical product segment.